Special Drug Use Investigation for Relenza (Zanamivir) (Prophylaxis)

Trial Profile

Special Drug Use Investigation for Relenza (Zanamivir) (Prophylaxis)

Phase of Trial: Phase IV

Latest Information Update: 22 May 2017

At a glance

  • Drugs Zanamivir (Primary)
  • Indications Influenza virus infections
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 13 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top